Premier Alternatives

Geneplus Technology

Beijing, China · Founded 2015 · In IPO Registration

Provider of gene sequencing and detection services intended for hospitals, research institutions, and pharmaceutical companies. Geneplus Technology is based in Beijing, China and was founded in 2015. Its last reported valuation was $605 million in Nov 2025. It has raised $186 million.

Last reported valuation
$604.6M
Oct 2026
Priced at
—
Total raised
$186.1M
Last round
—

Geneplus Technology key facts

as of Oct 2026
  • Provider of gene sequencing and detection services intended for hospitals, research institutions, and pharmaceutical companies.
  • Geneplus Technology is valued at approximately $604.6M as of Oct 2026 (last reported valuation).
  • It has raised $186.1M; the latest was IPO in Dec 2025.
  • Notable investors include Fortune Capital, Co-Stone Capital, Green Pine Capital Partners, Baidu Ventures, Highlight Capital — 27 tracked in total.
  • Status: In IPO Registration.
Last reported valuation
LOW confidence
$604.6M

Geneplus Technology's last reported valuation, Nov 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Geneplus Technology with a free account
  • ·The complete investor list: 27 names
  • ·Watch Geneplus Technology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Geneplus Technology funding rounds

No rounds on record

No funding rounds for Geneplus Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Geneplus Technology valuation

Geneplus Technology's last reported valuation was $605 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.

Geneplus Technology investors

27 investors are on record for Geneplus Technology, including Fortune Capital, Co-Stone Capital, Green Pine Capital Partners and Baidu Ventures. By type, the record holds 3 venture capital firms and 2 private equity firms.

About Geneplus Technology

Provider of gene sequencing and detection services intended for hospitals, research institutions, and pharmaceutical companies. The company's services provide integrated clinical and technological solutions, including tumor gene monitoring and detection, genetic testing and sequencing, and cancer genomics analysis, enabling medical practitioners to accurately and effectively detect, control, and prevent potential cancer-related risks.

Sector
Healthcare
HQ
Beijing, China
Founded
2015
Employees
810
Ownership
In IPO Registration

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.